Advisory Board

Gus Papathanasopoulos

Microlipid Technologies CEO Gus Papathanasopoulos

Founder and CEO

Gus Papathanasopoulos. Trained in both pharmacy and pathology, Gus has personally performed over 500,000 surgical specimen dissections and 1,200 autopsies. He was Manager/Supervisor of Anatomic Pathology Operations for Orlando Regional Healthcare System and has performed consulting work for the Lipshaw Company and other makers of anatomic pathology-related medical equipment. Gus received a full athletic scholarship from New York’s St. John’s University for fencing (he was the 1977 New York City epée champion and trained with the U.S. Olympic Team). After starting his professional studies in pharmacy, Gus effectively co-founded and became the first graduate of a ground-breaking St. John’s degree program: the Bachelor’s degree with major in Pathologist Assistant offered by the College of Pharmacy and Allied Health Professions. He also played a key role in curriculum development for the new program, which during the last three decades has substantially increased the profile, responsibility and pay of pathologist assistants.

As an undergraduate, Gus performed controlled experiments in qualitative tumor identification as an assistant to Dr. John V. Klavins, considered the father of—and world’s foremost expert in—tumor marker research. Dr. Klavins founded and edited (1986–1991) the Journal of Tumor Marker Oncology. Before shifting his focus to pathology, Gus had the opportunity to learn about pharmaceutical chemistry under the guidance of Bill Tomasulo, then Director of the prestigious Drug Information Center at New York’s Mercy Hospital (today known as Mercy Medical Center). Other influential associations Gus has benefited from include Dr. Henry J. Norris, a past Editor in Chief (1991–1994) of the International Journal of Gynecological Pathology; Dr. Gary S. Pearl, a renowned neuropathologist currently engaged in significant Alzheimer’s research; and Dr. Lizardo Cerezo, an internationally recognized hematopathologist and lymphoma expert. Dr. Cerezo serves as a technical advisor to Microlipid Technologies (see below).


Laurence Lurie. Mr. Lurie has over 32 years of healthcare industry experience. He held positions as Administrator of Miami Dade General Hospital, Administrator of Variety Children’s Hospital, Associate Administrator of South Miami Hospital and Administrator of the University of Miami’s Comprehensive Health Care Center. His experience also includes serving as Executive Director of the Florida Society of Internal Medicine for 18 years, as Executive Director of the Florida Chapter of the American College of Chest Physicians and as President and CEO of the Institute for Laboratory Medicine. Mr. Lurie graduated cum laude from Florida Atlantic University and earned a master’s degree in Hospital Administration from the Medical College of Virginia, Health Sciences Division of Virginia Commonwealth University.

Theresa L. Mason, Ph.D. Dr. Mason is a top-rated food scientist and our former liaison with Abitec Ltd. Abitec, a division of Associated British Foods, is the world’s largest manufacturer of structured lipids. As Technical Manager for Nutraceuticals, Dr. Mason played a key role in the regulatory approval process for the company’s medium chain triglycerides and other structured lipids, and she spearheaded novel nutraceutical conceps from idea to finished product. She also engineered joint ventures to expand the company’s share of the growing nutraceutical market. A frequent lecturer in food science and advanced food concepts, her career also includes work as a research scientist for Mars, Incorporated. Dr. Mason earned her bachelor’s degree in Biochemistry from Oklahoma State University and master’s and doctoral degrees in Food Science from Rutgers University.

Ferris H. Lander. Mr. Lander is a Biotechnology Specialist with McHale & Slavin, an intellectual property law firm based in Palm Beach Gardens, Florida. He is a former Primary Examiner and spent 25 years with the U.S. Patent & Trademark Office. Mr. Lander’s specialty is biotechnology, particularly technologies related to mass spectroscopic analysis of human disease markers and immunoassay techniques, organic compounds and fertilizer chemistry. His skills include the prosecution of Reissue and Reexamination applications, Interference and International patent practice and he is registered to practice before the U.S. Patent & Trademark Office. His professional experience and memberships include Ciba-Geigy Corporation as a Polymer Additives Chemist, membership in the U.S. Patent & Trademark Office Society, the Patent Law Association of South Florida and BioFlorida. Mr. Lander holds a B.S. in Chemical Engineering from Polytechnic Institute of Brooklyn.

Lizardo Cerezo, M.D. Dr. Cerezo is an internationally recognized expert in lymphoma and hematopathology with over 40 peer-reviewed publications and presentations. He has worked closely with our CEO and is involved in protocol development for proposed clinical trials of Microlipids™ cooking oil blends. He is board certified by the National Board of Medical Examiners (NBME) and by the The American Board of Pathology in anatomical and clinical pathology, with special competence in hematology. Dr. Cerezo is also a recipient of the American Medical Association Physician Recognition Award. His professional experience includes general surgical pathology, hematologic pathology, diagnostic electron microscopy, kidney biopsy interpretation and diagnostic flow cytometry. After graduating magna cum laude from the University of Puerto Rico Mayagüez College of Agriculture and Mechanical Arts, as the Charles Darwin Medal for Outstanding Biology Graduate, Dr. Cerezo earned his medical degree at the University of Puerto Rico School of Medicine.

Rear Admiral Raymond G. Jones, United States Navy (Retired). Admiral Jones’ active duty career spanned 34 years and included sea duty on six nuclear submarines. He commanded the fast attack submarine USS L. Mendel Rivers (SSN 686) and served as Commander Submarine Squadron 16 (nine fleet ballistic missile submarines); Commander Submarine Group Nine (responsible for all submarine operations, logistics and training in the Pacific Northwest); and Commander Naval Base Seattle (responsible for all Naval shore activities in Alaska, Washington and Oregon). His executive assignments included Deputy Chief of Staff Logistics Management for the Atlantic Submarine Force; Deputy Director of Navy Planning and Programming for the Chief of Naval Operations; Deputy Director of Submarine Warfare for the Chief of Naval Operations; Director of the Navy Personnel Policy and Navy Manpower; and Chief of Navy Technical Training Command. His awards include the Distinguished Service Medal and the Legion of Merit. Following his retirement, Admiral Jones worked as a senior executive and consultant in the nuclear power industry. He is currently Chair, Undersea Warfare at the Naval Postgraduate School, where he is also Director of the Wayne E. Meyer Institute of Systems Engineering. His interests include astronomy and serving on the Naval Submarine League Advisory Board. Admiral Jones graduated from the United States Naval Academy and earned a master’s degree in Management from Rensselaer Polytechnic Institute.

Captain, United States Army (Retired). He is a retired special operations officer and instructor, and our special forces liaison and extreme operational platform advisor. Career assignments included command of an elite team of special operations professionals tasked with National Security missions, including counter-terrorism. He also commanded an elite 30-man air mobile assault platoon, coordinated logistics and provided administrative support for global deployments of a 125-man special operations company. His familiarity with extreme environments includes arctic, desert, jungle, mountainous and temperate regions. Awards include the Army Achievement Medal, Army Commendation Medal and Joint Service Commendation Medal. His name must be withheld for security reasons.